乙肝2014程序.ppt

Hepatitis B乙型肝炎;Hepatitis;Virus associated hepatitis;Viral hepatitis;Hepatitis B;Hepatitis B virus;;;pre-s1;HBeAg与HBcAg一级结构的共线性;;;;1/4 9300万 慢性HBV感染者;Transmission course;;Epidemiological features;;Pathology of acute hepatitis ;嗜酸性变性;Pathology of chronic hepatitis ;Pathological grading (G) and staging (S) of chronic hepatitis ;Pathological degrees of chronic hepatitis ;;;Pathology of Fulminent/sub-fulminent hepatitis;;Coordinate activation of innate and adaptive response is necessary for HBV control ;对血液透析患者感染HBV后的动态随访：6月、12月、18月HBsAg的累积清除率，男性分别为31%、51%、59%，女性分别为46%、75%、86%;Clinical manifestation of acute hepatitis B;Clinical features of acute hepatitiswith different pathogens;Clinical manifestation of chronic hepatitis B;;;Clinical manifestation of fulminent/sub-fulminent hepatitis B;Hepatic encephalopathy;Fuminent/sub-fuminent hepatitis;Chemical tests ;Chemical tests ;Chemical tests ;;;;Virological tests;Medical imaging technology ;Diagnosis;Differential diagnosis;Natural history of chronic hepatitis B;Natural history of chronic hepatitis B;Natural history of chronic hepatitis B;Natural history of chronic hepatitis B;Natural history of chronic hepatitis B;Therapeutical principlesof acute hepatitis B;Goal of management for chronic hepatitis B ;Trerapeutical drugs for chronic hepatitis B ;;;;;Hepatoprotective drugs;Management regimens for fulminent/sub-fulminent hepatitis B;抗-HBs持续阳性的人群比例(%);